Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia. [electronic resource]
Producer: 20171215Description: 2552-2559 p. digitalISSN:- 1476-5551
- Clinical Trials, Phase IV as Topic
- Genotype
- HLA Antigens -- genetics
- Humans
- Immunotherapy
- Interleukin-2 -- pharmacology
- Killer Cells, Natural -- drug effects
- Leukemia, Myeloid, Acute -- diagnosis
- Ligands
- Lymphocyte Activation -- drug effects
- Multicenter Studies as Topic
- Prognosis
- Receptors, KIR -- genetics
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.